Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
That Marketing Solution, Inc. (TSTS)
Salt Lake City, UT, US
That Marketing Solution, Inc., a development stage company, focuses on the development, manufacturing, advertising, sale, and marketing of nutritional products. It acquired the rights to a proprietary formula for a blend of nutritional supplements called Low-T capsules that are intended to be a natural, non-FDA regulated, and over-the-counter supplement, which addresses the primary contributing factors of decreased levels of testosterone in males over the age of 30. The company was formerly known as Vista Holding Group, Corp. and changed its name to That Marketing Solution, Inc. in September 2014. That Marketing Solution, Inc. was founded in 2012 and is based in Salt Lake City, Utah.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +900.00% | +0.00% | +0.00% | +0.00% | -90.00% | -95.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Pharmaceuticals: +7.8%—
-
EPS growth Medical - Pharmaceuticals: +20.2%-460.0% Q4'15: -4,900.0% (vs Q4'14)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%-160,541.8% Q4'15: -280.3% (vs Q4'14)
-
EBIT margin Medical - Pharmaceuticals: +6.8%-105,832.1% Q4'15: -12,471.1% (vs Q4'14)
-
ROIC Medical - Pharmaceuticals: +6.1%— Q4'15: +449.9% (vs Q4'14)
-
Share dilution Medical - Pharmaceuticals: +0.0%+184.2% Q4'15: +49.9% (vs Q4'14)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×-0.50× Q4'15: -0.03× (vs Q4'14)
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Darren J. Lopez | Chairman, Chief Executive Officer, Treasurer and Secretary | 12.0K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TSTS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
